The Efficacy and Safety of Enzyme Preparations in Terms of Evidence-Based Medicine

A.E. Dorofeyev, S.A. Tarasenko

Abstract


The article deals with one of the most commonly prescribed group of drugs in gastroenterology — a group of enzyme preparations. Data from studies of their efficacy and safety are given. Although high-quality randomized controlled trials supporting the efficacy of enzyme preparations, as well as the benefits of specific enzyme preparations are practically nonexistent, based on clinical experience, they should still be considered as an effective therapeutic agents of the correction of exocrine pancreatic insufficiency and additional method for relief of pancreatic pain.


Keywords


enzyme preparations; trials; exocrine pancreatic insufficiency

References


Bansi D.S., Price A., Russel C. et al. Fibrosing colonopathy in an adult owing to over dose of pancreatic enzyme supplements // Gut. — 2000. — 46. — 283-285.

Borowitz D., Konstan M.W., O’Rourke A., Cohen M., Hendeles L., Murray F.T. Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis // J. Pediatr. Рharmacol. Ther. — 2007. — 12. — 47-52.

Burton F., Alkaade S., Collins D. et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States // Aliment. Pharmacol. Ther. — 2011. — 33. — 149-159.

De-Madaria E., Abad-González A., Aparicio J.R. et al. Spanish Pancreatic Club recommendation on diagnostic and treatment of chronic pancreatitis // Pancreatology. — 2013. — 13. — 18-28.

DiMagno E.P. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency // Best Pract. Res. Clin. Gastroenterol. — 2001. — 15. — 477-86.

Dominguez-Munoz J.E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis // Clin. Gastroenterol. Hepatol. — 2007. — 5. — 484-8.

Dominguez-Munoz J.E., Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? // JOP. — 2010. — 11. — 158-62.

Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Figueiras A., Vilarino-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study // Aliment. Pharmacol. Ther. — 2005. — 21. — 993-1000.

Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Vilarino-Insua M. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts // Gut. — 2006. — 55. — 1056-7.

Giuliano S.A., Dehoorne-Smith M.L., Kale-Pradhan P.B. Pancreatic enzyme products // Ann. Pharmaсother. — 2011. — 45. — 658-666.

Federal Register cited (69 82); Docket No. 2003N-0205. Available at: http:// www.fda.gov/OHRMS/DOCKETS/98fr/04-9652.htm (accessed 25 October 2009).

Ferrone M., Raimondo M., Scolapio J.S. Pancreatic enzyme pharmacotherapy // Рharmacotherapy. — 2007. — 27. — 910-920.

Fieker A., Philpott J., Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future // Clin. Exp. Gastroenterol. — 2011. — 4. — 55-73.

FDA. Guidance for Industry Exocrine Pancreatic Insufficiency Drug Products // Services USDoHaH, ed. — Rockville, MD, 2006.

Forsmark C. Management of Chronic Pancreatitis // Gastroenterology. — 2013. — 144. — 1282-1291.

Frulloni L., Falconi M., Gabbrielli A., Gaia E., Graziani R., Pezzilli R. et al. Italian consensus guidelines for chronic pancreatitis // Dig. Liver Dis. — 2010. — 42 (Suppl. 6). — S381-406.

Kadiyala V., Suleiman S., Conwell D. Pancreatic exocrine insufficiency // Gastroentero&Endoscopy News. — June 2012. — 1-11.

Kalnins D., Ellis L., Corey M. et al. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis // J. Pediatr. Gastroenterol. Nutr. — 2006. — 42. — 256-61.

Konstan M.W., Stern R.C., Trout J.R. et al. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy // Aliment. Pharmacol. Ther. — 2004. — 20. — 1365-71.

Layer P., Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives // Pancreas. — 2003. — 26. — 1-7.

Ljeb J.G. II & Forsmark C.E. Review article: pain and chronic pancreatitis // Aliment. Pharmacol. Ther. — 2009. — 29. — 706-719.

Safdi M., Bekal P.K., Martin S., Saeed Z.A., Burton F., Toskes P.P. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis // Pancreas. — 2006. — 33. — 156-62.

Santini B., Antonelli M., Battistini A. et al. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis // Dig. Liver Dis. — 2000. — 32. — 406-11.

Shafiq N., Rana S., Bhasin D., Pandhi P., Srivastava P., Sehmby S.S. et al. Pancreatic enzymes for chronic pancreatitis // Cochrane Database Syst. Rev. — 2009. — CD006302.

Stallings V.A., Stark L.J., Robinson K.A. et al. Evidence-based practical recomendations for nutritionrelated management of children and adults with cystic fibrosis and pancreatic insufficiency: results of systematic review // J. Am. Diet. Assoc. — 2008. — 108. — 832-839.

Taylor J.R., Gardner T.B., Waljee A.K., DiMagno M.J., Schoenfeld P.S. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency // Aliment. Pharmacol. Ther. — 2010. — 31. — 57-72.

Toouli J., Biankin A.V., Oliver M.R. et al. Management of pancreatic exocrine insufficiency: Austral-Asian Pancreatic Club recommendations // Med. J. Austr. — 2010. — 193. — 461-467.

Van Esch A.A., Wilder-Smith O.H., Jansen J.B., van Goor H., Drenth J.P. Pharmacological management of pain in chronic pancreatitis // Dig. Liver Dis. — 2006. — 38. — 518-26.

Vecht J., Symersky T., Lamers C.B., Masclee A.A. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency // J. Clin. Gastroenterol. — 2006. — 40. — 721–5. — PMID: 16940886.

Waljee A.K., Dimagno M.J., Wu B.U., Schoenfeld P.S., Conwell D.L. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis // Aliment. Pharmacol. Ther. — 2009. — 29. —

-46.

Whitcomb D.C., Yadav D., Slivka A. et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2) // Pancreatology. — 2008. — 8. — 520-31.

Whitcomb D.C., Lehman G.A., Vasileva G., Malecka-Panas E., Gubergrits N., Shen Y. et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial // Am. J. Gastroenterol. — 2010. — 105. — 2276-86.

Winstead N.S., Wilcox C.M. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis: a review // Pancreatology. — 2009. — 9. — 344-50.




DOI: https://doi.org/10.22141/2308-2097.3.49.2013.86330

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru